keyword
MENU ▼
Read by QxMD icon Read
search

Anemia, cancer, cardiology

keyword
https://www.readbyqxmd.com/read/21962727/gastrointestinal-malignancies-and-cardiovascular-diseases-non-negligible-comorbidity-in-an-era-of-multi-antithrombotic-drug-use
#1
REVIEW
Nobukazu Ishizaka, Aiko Sakamoto, Mitsuhiro Fujishiro, Ryozo Nagai, Kazuhiko Koike
Nowadays, antiplatelet and anticoagulant drug medications are indicated in patients with a variety of cardiovascular disorders, such as atrial fibrillation, coronary artery disease, and peripheral artery disease. Among cardiology patients, regardless of gastrointestinal (GI) protection, we do not infrequently encounter those patients who have signs and symptoms that are suggestive of GI tract problems. We should bear in mind that such GI signs and symptoms may be attributed to GI cancers, as well as to benign or clinically insignificant lesions...
November 2011: Journal of Cardiology
https://www.readbyqxmd.com/read/20495204/high-cumulative-incidence-of-cancer-in-patients-with-cardio-renal-anaemia-syndrome
#2
COMPARATIVE STUDY
Nicolas F Schroten, Karien van der Putten, Frans H Rutten, Adry Diepenbroek, Arend Mosterd, Carlo A J M Gaillard
AIMS: The combination of chronic kidney disease (CKD), chronic heart failure (HF), and anaemia, the so-called cardio-renal-anaemia syndrome (CRA) is associated with dysregulation of erythropoietin levels and inflammation. Both have been associated with the development of cancer. This study aimed to determine the cumulative incidence of cancer in patients with CRA, as compared with anaemic CKD and control patients. METHODS AND RESULTS: Patients aged <80 years who attended the nephrology or cardiology outpatient clinics between March 2006 and November 2007 were eligible for inclusion in this retrospective case-control study if haemoglobin <8...
August 2010: European Journal of Heart Failure
https://www.readbyqxmd.com/read/19789122/-erythropoietin-indications-and-measurement
#3
REVIEW
E Klein, A Georges, J Brossaud, K de Bosredon, L Bordenave, J-B Corcuff
Erythropoietin (EPO) is the principal haematopoietic growth factor of the red blood cell line. Its major role is to stimulate the red blood cell production. EPO synthesis by peritubular cells in the kidney is regulated by oxygen concentration and must lead adaptation of the organism to face many different physiological situations. An imbalance can lead either to anaemia or polycythemia. Synthetic EPO, so-called recombinant, has definitively changed the treatment in the anaemia of chronic renal failure and regularly find new indications, legal (anaemia of cancer, anaemia of chronic inflammatory syndromes, myelodysplastic syndromes, neurology, cardiology...
September 2009: Annales de Biologie Clinique
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"